# DESCRIPTION

## FIELD OF THE INVENTION

## BACKGROUND

## BRIEF SUMMARY OF THE INVENTION

## DETAILED DESCRIPTION

### Definitions

### Germline Mutations

### Binding Properties of the Antibodies

### Bispecific Antigen-Binding Molecules

### Sequence Variants

### Antibodies Comprising Fc Variants

### Biological Characteristics of the Antibodies and Bispecific Antigen-Binding Molecules

### Epitope Mapping and Related Technologies

### Preparation of Antigen-Binding Domains and Construction of Bispecific Molecules

## EXAMPLES

### Example 1: Generation of Anti-PSMA Antibodies

### Example 2: Heavy and Light Chain Variable Region Amino Acid and Nucleic Acid Sequences of Anti-PSMA Antibodies

### Example 3: Surface Plasmon Resonance Derived Binding Affinities and Kinetic Constants of Human Monoclonal Anti-PSMA Antibodies

### Example 4: Generation of Bispecific Antibodies that Bind Prostate-Specific Membrane Antigen (PSMA) and CD3

### Example 5: Binding Affinities of Exemplified Bispecific Antibodies as Measured by FACS Analysis

### Example 6: Binding Affinities of Exemplified Antibodies as Measured by a Surface Plasmon Resonance Binding Assay

### Example 7: T Cell Activation and Tumor-Specific Cytotoxicity Exhibited by Bispecific Antibodies of the Invention as Measured In Vitro

### Example 8: Anti-PSMA/Anti-CD3 Bispecific Antibodies Display Potent Anti-Tumor Efficacy In Vivo

### Example 9: Generation of Anti-CD3 Antibodies

